Hemolytics
Fribourg
About Hemolytics
Hemolytics is a MedTech company that develops a chemical amplification method for ultrasensitive detection of malaria using inexpensive reagents. It may be used as a point of care diagnostic test kit with a sensitivity 10-fold superior to that of the most sophisticated currently available malaria rapid diagnostic tests (MRDT).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.9K
- Last round: Grant (Oct 2018)
- Website: hemolytics.ch
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hemolytics-2202354 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.